norverapamil has been researched along with Bradyarrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleinschmidt, KC; Velez, LI; Young, AC | 1 |
| Cordon-Cardo, C; Fischer, P; Lianes, P; Lyn, P; Motzer, RJ; Ngo, RL; O'Brien, JP | 1 |
1 trial(s) available for norverapamil and Bradyarrhythmia
| Article | Year |
|---|---|
Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bradycardia; Carcinoma, Renal Cell; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Hypotension; Immunohistochemistry; Kidney Neoplasms; Male; Middle Aged; Stereoisomerism; Tumor Cells, Cultured; Verapamil; Vinblastine | 1995 |
1 other study(ies) available for norverapamil and Bradyarrhythmia
| Article | Year |
|---|---|
Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose.
Topics: Adult; Bradycardia; Calcium Channel Blockers; Delayed-Action Preparations; Drug Overdose; Electrocardiography; Fat Emulsions, Intravenous; Humans; Male; Verapamil | 2009 |